PhaseBio Pharmaceuticals Inc.
PHAS
|
|
| |
|
| Trading Volume | 134,000 |
|
|
0.00 - 0.00 |
| Market Cap Full | $ 44.9M |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | - | - | - | -43.7% |
| Q2 | - | - | - | -59.2% |
| Q3 | - | - | - | 50% |
| Q4 | - | - | - | - |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| - | - | - | - | - | - | - | - | - | - | - | - |
| 2023 | |||||||||||
| - | - | - | - | - | - | - | - | - | - | - | - |
| 2022 | |||||||||||
| -24.5 | -42.6 | 30.1 | -17.7 | -34.1 | -24.8 | 86.7 | -5.4 | -15.1 | - | - | - |
| 2021 | |||||||||||
| 14.6 | 3.8 | -13.5 | -12.4 | 11.6 | 10.1 | -5.7 | -7.7 | -4 | 21.7 | -44.1 | 23.4 |
| 2020 | |||||||||||
| -25.1 | -10 | -21.8 | 16.6 | 55.7 | -23.5 | -13 | -3.5 | -9.1 | -22.2 | 38.8 | -11.4 |
EPS
| 2021 | 2020 | |
|---|---|---|
| Q1 | -0.9 | -0.5 |
| Q2 | -0.6 | -1 |
| Q3 | 0 | -0.9 |
| Q4 | 0 | -1 |
| A | -3 | -3.4 |